Andreas Sauerbrei

ORCID: 0000-0003-3183-8538
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Herpesvirus Infections and Treatments
  • Poxvirus research and outbreaks
  • Cytomegalovirus and herpesvirus research
  • Virus-based gene therapy research
  • Influenza Virus Research Studies
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Bartonella species infections research
  • Respiratory viral infections research
  • Food Allergy and Anaphylaxis Research
  • Toxin Mechanisms and Immunotoxins
  • Vector-borne infectious diseases
  • Viral Infections and Immunology Research
  • Parvovirus B19 Infection Studies
  • Hepatitis Viruses Studies and Epidemiology
  • Viral-associated cancers and disorders
  • Animal Disease Management and Epidemiology
  • Medical Device Sterilization and Disinfection
  • Pneumonia and Respiratory Infections
  • Systemic Lupus Erythematosus Research
  • Acne and Rosacea Treatments and Effects
  • Dermatology and Skin Diseases
  • Plant Virus Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research

Friedrich Schiller University Jena
2012-2023

Jena University Hospital
2014-2023

Center for Clinical Studies
2014-2015

Schiller International University
2003-2014

Institute of Virology of the Slovak Academy of Sciences
2013

Karolinska Institutet
2012

Wayne State University
2008

Sarepta Therapeutics (United States)
2000

Klinikum Chemnitz
1996

Medizinische Akademie Erfurt
1987-1992

SUMMARY Acute parvovirus B19 infection is a risk for pregnant women. After vertical transmission the infected fetus may develop hydrops fetalis. Since occurs mainly during childhood, children represent main source virus transmission. In order to determine whether certain groups in German population show increased risks we analysed seroprevalence using 6583 sera collected from adults former Eastern and Western Germany National Health Survey 649 healthy Thuringian adolescents. overall was...

10.1017/s0950268807009958 article EN Epidemiology and Infection 2008-01-16

10.1016/s1386-6532(99)00042-6 article EN Journal of Clinical Virology 1999-09-01

This study was carried out to determine the prevalence of antibodies herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) in selected German populations, such as blood donors, hospital patients, human immunodeficiency (HIV)-seropositive individuals. Serum samples collected between 1996 1998 were tested by enzyme immunoassays using monoclonal antibody-selected native gG1 gG2 antigens an immunoblot type-specific recombinant glycoproteins. Equivocal results resolved "in-house" Western blot assay....

10.1002/(sici)1096-9071(200006)61:2<201::aid-jmv5>3.0.co;2-p article EN Journal of Medical Virology 2000-06-01

Herpes simplex virus type 1 is a common cause of severe sporadic encephalitis. Treatment with acyclovir highly effective in this disease. We report the case 27-year-old, immunocompetent woman acyclovir-resistant herpes Although she had not been treated before, DNA from cerebrospinal fluid showed non-synonymous mutation thymidine kinase gene, which likely to have caused resistance acyclovir. encephalitis resolved after treatment foscarnet. To our knowledge, first an immunocompetent,...

10.1002/ana.21979 article EN Annals of Neurology 2010-01-20

ABSTRACT Genotyping of 21 varicella-zoster virus (VZV) strains using a scattered single nucleotide polymorphism (SNP) method revealed ambiguous SNPs and two nontypeable isolates. For further genetic characterization, the genomes all were sequenced 454 technology. Almost-complete genome sequences assembled, most remaining gaps closed with Sanger sequencing. Phylogenetic analysis 42 five established novel VZV genotypes, provisionally termed VIII IX. Genotypes IX are distinct from previously...

10.1128/jvi.06233-11 article EN Journal of Virology 2011-12-02

Since the introduction of varicella vaccination in several countries, there has been an urgent need for commercially available test procedures that allow highly sensitive and specific quantitative determination varicella-zoster virus (VZV)-specific immune status, including immunity postimmunization. This study compared performance two enzyme-linked immunosorbent assays (ELISAs) VZV-specific immunoglobulin G (IgG) seronegative latently infected persons, as well vaccinees. One ELISA is based...

10.1128/jcm.00719-06 article EN Journal of Clinical Microbiology 2006-09-01

10.1007/s00705-008-0264-x article EN Archives of Virology 2008-11-27
Coming Soon ...